GSK215 |
GSK215 : Degrader (PROTAC) of PTK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PTK2 |
|
|
Degrader (PROTAC)
up to 100 nM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
Profiling of GSK215 using a cell lysate kinobead assay showed that the PROTAC maintained high select ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
GSK215 was further assessed by multiplexed proteome dynamics profiling (mPDP): In mature proteins, G ...
Selectivity Assessment Description:
After 24 h treatment, the selectivity of degradation for GSK215 was maintained up to 10 nM while at ...
Potency Cellular
In Vitro
PTK2
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? No
DOI Reference: 10.1002/anie.202109237
In Vivo Validations
Mouse
Dose: 8 mg/Kg
Route of delivery:
Subcutaneous
Cmax:
526 ng/mL
Tmax:
0.33 h
DOI Reference: 10.1002/anie.202109237
Negative Control Compounds
ent-6
Notes: ent-6 does not degrade FAK
SMILES:
C[C@H](C1=CC=C(C=C1)C2=C(C)N=CS2)NC(=O)[C@H]3C[C@@H](CN3C(=O)[C@@H](C(C)(C)C)NC(=O)CN4CCN(CC4)C5=CC(=C(C=C5)NC6=NC=C(C(=C6)NC7=C(C=CC=C7)C(=O)NC)C(F)(F)F)OC)O
Chemical Information
| Molecular Formula | C50H59F3N10O6S |
| SMILEs | CNC(=O)c1ccccc1Nc1cc(Nc2ccc(N3CCN(CC(=O)N[C@H](C(=O)N4C[C@H](O)C[C@H]4C(=O)N[C@@H](C)c4ccc(-c5scnc5C)cc4)C(C)(C)C)CC3)cc2OC)ncc1C(F)(F)F |
| InChI | InChI=1S/C50H59F3N10O6S/c1-29(31-12-14-32(15-13-31)44-30(2)56-28-70-44)57-47(67)40-23-34(64)26-63(40)48(68)45(49(3,4)5)60-43(65)27-61-18-20-62(21-19-61)33-16-17-38(41(22-33)69-7)59-42-24-39(36(25-55-42)50(51,52)53)58-37-11-9-8-10-35(37)46(66)54-6/h8-17,22,24-25,28-29,34,40,45,64H,18-21,23,26-27H2,1-7H3,(H,54,66)(H,57,67)(H,60,65)(H2,55,58,59)/t29-,34+,40-,45+/m0/s1 |
| Molecular weight | 984.43 Da |
| AlogP | 6.879820000000007 |
| HBond acceptors | 16 |
| HBond donors | 6 |
| Atoms | 129 |